SCHEMBL10073816

SCHEMBL10073816

COC(=O)Oc1ccccc1S(=O)(=O)/N=C/c1ccc(C)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.47
POLB P06746 1/20 0.41
HPGD P15428 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HSD17B10 Q99714 1/20 0.40
LMNA P02545 5/20 0.40
CASP1 P29466 1/20 0.39
KMT2A Q03164 6/20 0.39
MEN1 O00255 5/20 0.39
MAPT P10636 4/20 0.39
NPSR1 Q6W5P4 2/20 0.39
HTT P42858 2/20 0.39
ALOX12 P18054 1/20 0.39
GLA P06280 1/20 0.38
RAB9A P51151 1/20 0.38
PAX8 Q06710 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ATM Q13315 1/20 0.38
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12444229 0.80 CA1 (0.51) ALDH1A1POLBHPGDKDM4EHSD17B10
SCHEMBL10073001 0.75 ALDH1A1 (0.51) ALDH1A1POLBHPGDKDM4ELMNA
SCHEMBL10047342 0.75 ALDH1A1 (0.47) ALDH1A1POLBHPGDKDM4ELMNA
SCHEMBL13493932 0.75 F2 (0.51) ALDH1A1POLBHPGDKDM4EHSD17B10
SCHEMBL15975333 0.73 ALDH1A1 (0.49) ALDH1A1POLBHPGDKDM4ELMNA
SCHEMBL1933496 0.69 ALDH1A1 (0.69) ALDH1A1POLBKDM4ELMNAKMT2A
SCHEMBL1933497 0.69 ALDH1A1 (0.69) ALDH1A1POLBKDM4ELMNAKMT2A
SCHEMBL12515611 0.69 F2 (0.51) ALDH1A1POLBHPGDLMNAKMT2A
SCHEMBL10047327 0.68 ALDH1A1 (0.51) ALDH1A1POLBLMNAKMT2AMEN1
SCHEMBL10047334 0.68 CA1 (0.50) ALDH1A1POLBHPGDKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093274-B2 Inhibitors of protein prenyltransferases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-01-10 US disclosed
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-03-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063114-A1 INHIBITORS OF PROTEIN PRENYLTRANSFERASES GGT1, FNTA, FNTB ALDH1A1 1074/4885POLB 2318/4885HPGD 816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.